Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development
The DOI matches its Crossref record; 134 of the 134 references it cites were found in a registry or an index.
Abstract
Muscarinic acetylcholine receptors (mAChRs), M(1)-M(5), regulate the activity of numerous fundamental central and peripheral functions. The lack of small-molecule ligands that can block or activate specific mAChR subtypes with high selectivity has remained a major obstacle in defining the roles of the individual receptor subtypes and in the development of novel muscarinic drugs. Recently, phenotypic analysis of mutant mouse strains deficient in each of the five mAChR subtypes has led to a wealth of new information regarding the physiological roles of the individual receptor subtypes. Importantly, these studies have identified specific mAChR-regulated pathways as potentially novel targets for the treatment of various important disorders including Alzheimer's disease, schizophrenia, pain, obesity and diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The Gq/11-coupled M1, M3 and M5 mAChRs elicit Ca2+ release from the endoplasmic reticulum (ER) by activating the downstream phospholipase C/inositol 1,4,5-trisphosphate/inositol 1,4,5-trisphosphate receptor (PLC/IP3/IP3R) cascade49, the same pathway triggered by TCR signaling.”
From Tumor-specific cholinergic CD4+ T lymphocytes guide immunosurveillance of hepatocellular carcinoma (2023) · cites this paper as [49]
Citations
Cites
Goodman & Gilman's The Pharmacological Basis of Therapeutics
Brunton, L. L. (1985) · Cited by 7,321
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
Goodman and Gilman's the Pharmacological Basis of Therapeutics
Stigelman, W. H., & Pharm, D. (1986) · Military Medicine · doi:10.1093/milmed/151.1.386 · Cited by 6,782
The role of acetylcholine in learning and memory
Hasselmo, M. E. (2006) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2006.09.002 · Cited by 1,693 · cited 1×
“Alzheimer's disease and cognitive impairments A convincing body of data indicate that mAChRs have central roles in facilitating cognitive function”
BackgroundInternational Union of Pharmacology. XVII. Classification of Muscarinic Acetylcholine Receptors
Caulfield, M. P., & Birdsall, N. J. M. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01362-0 · Cited by 1,474
Muscarinic Receptors—Characterization, coupling and function
Caulfield, M. P. (1993) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(93)90027-b · Cited by 1,277
Wise, R. A. (1996) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(96)80079-1 · Cited by 1,072
Koob, G. F., Sanna, P. P., & Bloom, F. E. (1998) · Neuron · doi:10.1016/s0896-6273(00)80557-7 · Cited by 1,026
The current status of the dopamine hypothesis of schizophrenia
CARLSSON, A. (1988) · Neuropsychopharmacology · doi:10.1016/0893-133x(88)90012-7 · Cited by 958
Autonomic regulation of islet hormone secretion - Implications for health and disease
Ahrén, B. (2000) · Diabetologia · doi:10.1007/s001250051322 · Cited by 909
Cited by
Items 301–400 of 671
Coccini, T., Crevani, A., Rossi, G., Assandri, F., Balottin, U., Nardo, R. D., & Manzo, L. (2009) · Biomarkers · doi:10.3109/13547500903144436 · Cited by 21
Baker, S., Chin, C., Basso, A. M., Fox, G. B., Marek, G. J., & Day, M. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.188797 · Cited by 21
Lawrence, J. J., Haario, H., & Stone, E. F. (2015) · Journal of Neurophysiology · doi:10.1152/jn.00167.2014 · Cited by 19
Böck, A., & Mohr, K. (2013) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2012.12.003 · Cited by 25
Nagy, P. M., & Aubert, I. (2013) · Brain and Behavior · doi:10.1002/brb3.139 · Cited by 20
Lithium treatment attenuates muscarinic M1 receptor dysfunction: M1receptor sensitivity to lithium
Creson, T. K., Austin, D. R., Shaltiel, G., McCammon, J., Wess, J., Manji, H. K., & Chen, G. (2011) · Bipolar Disorders · doi:10.1111/j.1399-5618.2011.00915.x · Cited by 20
Self-citationWelt, T., Kulic, L., Hoey, S. E., McAfoose, J., Späni, C., Chadha, A. S., Fisher, A., & Nitsch, R. M. (2015) · Journal of Alzheimer’s Disease · doi:10.3233/jad-150152 · Cited by 20
Deng, A. Y., deBlois, D., Laporte, S. A., Gélinas, D., Tardif, J., Thorin, É., Shi, Y., Raignault, A., & Ménard, A. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11385 · Cited by 20
Luchese, C., Prigol, M., Acker, C. I., & Nogueira, C. W. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.06.047 · Cited by 20
3-iodothyronamine (T1AM), a novel antagonist of muscarinic receptors
Laurino, A., Matucci, R., Vistoli, G., & Raimondi, L. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.10.027 · Cited by 21
Fisher, S. K., & Wonnacott, S. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-374947-5.00013-4 · Cited by 27
Targeting G Protein-Coupled Receptors in the Treatment of Parkinson’s Disease
Jones-Tabah, J. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167927 · Cited by 20
Akbarzadeh, R., Müller, A., Humrich, J. Y., & Riemekasten, G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1213804 · Cited by 24
Cholinergic Mechanisms in Gastrointestinal Neoplasia
Moura, N. S., Schledwitz, A., Alizadeh, M. A., Kodan, A., Njei, L., & Raufman, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105316 · Cited by 21
New insight into active muscarinic receptors with the novel radioagonist [3H]iperoxo
Schrage, R., Holze, J., Klöckner, J., Balkow, A., Klause, A. S., Schmitz, A.-L., Amici, M. D., Kostenis, E., Tränkle, C., Holzgrabe, U., et al. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.05.012 · Cited by 26
Kuroiwa, M., Hamada, M., Hieda, E., Shuto, T., Sotogaku, N., Flajolet, M., Snyder, G. L., Hendrick, J. P., Fienberg, A. A., & Nishi, A. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.07.046 · Cited by 22
Stewart, G. D., Sexton, P. M., & Christopoulos, A. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.064253 · Cited by 19
Muramatsu, I., Uwada, J., Yoshiki, H., Sada, K., Lee, K., Yazawa, T., Taniguchi, T., Nishio, M., Ishibashi, T., & Masuoka, T. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14701 · Cited by 21
Muscarinic acetylcholine receptor regulates self-renewal of early erythroid progenitors
Trivedi, G., Inoue, D., Chen, C., Bitner, L. E., Chung, Y. R., Taylor, J., Gönen, M., Wess, J., Abdel-Wahab, O. I., & Zhang, L. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw3781 · Cited by 23
Self-citationMeister, J., Wang, L., Pydi, S. P., & Wess, J. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15314 · Cited by 22
Self-citationŽužek, M. C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25169049 · Cited by 19
Zhang, C., Guo, X., Wang, Y., Zhang, S., & Wang, Z. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02441-4 · Cited by 33
Organic Toxins as Tools to Understand Ion Channel Mechanisms and Structure
Morales‐Lázaro, S. L., Hernández‐García, E., Serrano‐Flores, B., & Rosenbaum, T. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150217110710 · Cited by 18
Bello, F. D., Bonifazi, A., Giorgioni, G., Petrelli, R., Quaglia, W., Altomare, A., Falcicchio, A., Matucci, R., Vistoli, G., & Piergentili, A. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.06.004 · Cited by 18
GPCR drug discovery-moving beyond the orthosteric to the allosteric domain
Felder, C. C. (2019) · Advances in pharmacology · doi:10.1016/bs.apha.2019.04.002 · Cited by 19
Advances in molecular imaging for the diagnosis of dementia
Okamura, N., Fodero‐Tavoletti, M. T., Kudo, Y., Rowe, C. C., Furumoto, S., Arai, H., Masters, C. L., Yanai, K., & Villemagne, V. L. (2009) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530050903133790 · Cited by 19
Stahl, E. L., Elmslie, G., & Ellis, J. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.072991 · Cited by 18
Melancon, B. J., Gogliotti, R. D., Tarr, J. C., Saleh, S. A., Chauder, B. A., Lebois, E. P., Cho, H. P., Utley, T. J., Sheffler, D. J., Bridges, T. M., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.03.088 · Cited by 17
Bakr, M. N., Takahashi, H., & Kikuchi, Y. (2023) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2023.101425 · Cited by 19
Hagio, H., Koyama, W., Hosaka, S., Song, A. D., Narantsatsral, J., Matsuda, K., Sugihara, T., Shimizu, T., Koyanagi, M., Terakita, A., et al. (2023) · eLife · doi:10.7554/elife.83974 · Cited by 18
Ligand bias at the muscarinic acetylcholine receptor family: Opportunities and challenges
Kaoullas, M. G., Thal, D. M., Christopoulos, A., & Valant, C. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110092 · Cited by 20
Suharni, Nomura, Y., Arakawa, T., Hino, T., Abe, H., Nakada-Nakura, Y., Sato, Y., Iwanari, H., Shiroishi, M., Asada, H., et al. (2014) · Monoclonal Antibodies in Immunodiagnosis and Immunotherapy · doi:10.1089/mab.2014.0041 · Cited by 18
Beta-cell M3 muscarinic acetylcholine receptors as potential targets for novel antidiabetic drugs
Zhu, L., Rossi, M., Doliba, N. M., & Wess, J. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106267 · Cited by 19
Self-citationEffects of modulating M3 muscarinic receptor activity on azoxymethane-induced liver injury in mice
Khurana, S., Jadeja, R. N., Twaddell, W. S., Cheng, K., Rachakonda, V. P., Saxena, N. K., & Raufman, J. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.05.010 · Cited by 17
Bender, A. M., Cho, H. P., Nance, K. D., Lingenfelter, K. S., Luscombe, V. B., Gentry, P. R., Voigtritter, K. R., Berizzi, A. E., Sexton, P. M., Langmead, C. J., et al. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00126 · Cited by 16
Ueda, H., Mitoh, Y., Fujita, M., Kobashi, M., Yamashiro, T., Sugimoto, T., Ichikawa, H., & Matsuo, R. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.05.029 · Cited by 16
Increased Metabolic Potential, Efficacy, and Safety of Emerging Treatments in Schizophrenia
Meyer, J. M., & Correll, C. U. (2023) · CNS Drugs · doi:10.1007/s40263-023-01022-7 · Cited by 23
Sévoz‐Couche, C., Liao, W., Foo, H. Y. C., Bonne, I., Lu, T. B., Hui, C. T. Q., Azhar, S. H., Peh, W. Y. X., Yen, S., & Wong, W. S. F. (2024) · British Journal of Pharmacology · doi:10.1111/bph.16334 · Cited by 18
Phenotype pharmacology of lower urinary tract α1‐adrenoceptors
Nishimune, A., Yoshiki, H., Uwada, J., Anisuzzaman, A. S. M., Umada, H., & Muramatsu, I. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01591.x · Cited by 16
Suwa, A., Konishi, Y., Uruno, Y., Takai, K., Nakako, T., Sakai, M., Enomoto, T., Ochi, Y., Matsuda, H., Kitamura, A., et al. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.04.083 · Cited by 18
Bhattacharjee, A. K., Pomponio, J. W., Evans, S. A., Pervitsky, D., & Gordon, R. K. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.01.072 · Cited by 21
Novel Fused Arylpyrimidinone Based Allosteric Modulators of the M1 Muscarinic Acetylcholine Receptor
Mistry, S. N., Lim, H. D., Jörg, M., Capuano, B., Christopoulos, A., Lane, J. R., & Scammells, P. J. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00018 · Cited by 16
Staszewski, M., Nelic, D., Jończyk, J., Dubiel, M., Frank, A., Stark, H., Bajda, M., Jakubík, J., & Walczyński, K. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00237 · Cited by 16
Melancon, B. J., Utley, T. J., Sevel, C., Mattmann, M. E., Cheung, Y., Bridges, T. M., Morrison, R. D., Sheffler, D. J., Niswender, C. M., Daniels, J. S., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.06.018 · Cited by 16
Engineered Allosteric Regulation of Protein Function
Fauser, J., Leschinsky, N., Szynal, B. N., & Karginov, A. V. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167620 · Cited by 17
Current Status of Oligonucleotide-Based Protein Degraders
Shih, P., Naganuma, M., Demizu, Y., & Naito, M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030765 · Cited by 15
A New Aspect of Cholinergic Transmission in the Central Nervous System
Muramatsu, I., Masuoka, T., Uwada, J., Yoshiki, H., Yazama, T., Lee, K., Sada, K., Nishio, M., Ishibashi, T., & Taniguchi, T. (2018) · Springer eBooks · doi:10.1007/978-981-10-8488-1_3 · Cited by 16
Muramatsu, I., Yoshiki, H., Uwada, J., Masuoka, T., Sada, K., Taniguchi, T., & Nishio, M. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13843 · Cited by 15
Su, D., Wang, M., Ye, C., Fang, J., Duan, Y., Zhang, Z., Hua, Q., Shi, C., Zhang, L., Zhang, R., et al. (2017) · Scientific Reports · doi:10.1038/srep44476 · Cited by 16
Muscarinic Acetylcholine Receptor Subtypes in the Male Reproductive Tract
Avellar, M. C. W., Siu, E. R., Yasuhara, F., Maróstica, E., & Porto, C. S. (2009) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9268-6 · Cited by 15
Muscarinic acetylcholine receptors as therapeutic targets for obesity
Maresca, A., & Supuran, C. T. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.9.1167 · Cited by 15
Fischer, O., Hofmann, J., Rampp, H., Kaindl, J. M., Pratsch, G., Bartuschat, A. L., Taudte, R. V., Fromm, M. F., Hübner, H., Gmeiner, P., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00297 · Cited by 15
Cholinergic Antagonists and Behavioral Disturbances in Neurodegenerative Diseases
Mahmoudi, R., Novella, J., Badr, S., Boulahrouz, S., Tran, D. D., Morrone, I., & Jaïdi, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24086921 · Cited by 17
Muscarinic control of cardiovascular function in humans: a review of current clinical evidence
Palma, J. (2024) · Clinical Autonomic Research · doi:10.1007/s10286-024-01016-5 · Cited by 17
Molecular mechanism of muscarinic acetylcholine receptor M3 interaction with Gq
Ham, D., Inoue, A., Xu, J., Du, Y., & Chung, K. Y. (2024) · Communications Biology · doi:10.1038/s42003-024-06056-1 · Cited by 15
Ein photoschaltbarer Ligand zur Regulierung der Rezeptoraktivierung
Agnetta, L., Kauk, M., Cañizal, M. C. A., Messerer, R., Holzgrabe, U., Hoffmann, C., & Decker, M. W. (2017) · Angewandte Chemie · doi:10.1002/ange.201701524 · Cited by 14
Lambert, L., Dubayle, D., Fafouri, A., Herzog, É., Csaba, Z., Dournaud, P., Mestikawy, S. E., & Bernard, V. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00450 · Cited by 14
Wang, Y., Zuo, Z., Zhang, M., Feng, Z., Yan, M., & Li, X. (2016) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000001755 · Cited by 15
Muramatsu, I., Uwada, J., Masuoka, T., Yoshiki, H., Sada, K., Lee, K., Nishio, M., Ishibashi, T., & Taniguchi, T. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14127 · Cited by 14
Influence of MT7 toxin on the oligomerization state of the M1muscarinic receptor1
Marquer, C., Fruchart‐Gaillard, C., Mourier, G., Grandjean, O., Girard, E., le Maire, M., Brown, S., & Servent, D. (2010) · Biology of the Cell · doi:10.1042/bc20090171 · Cited by 15
Shoukat, S., Zia, M. A., Uzair, M., Alsubki, R. A., Sajid, K., Shoukat, S., Attia, K. A., Fiaz, S., Ali, S., Kimiko, I., et al. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08674-0 · Cited by 15
M1/M4 receptors as potential therapeutic treatments for schizophrenia: A comprehensive study
Fu, L., Luo, Y., Niu, L., Lin, Y., Chen, X., Zhang, J., Tang, W., Chen, Y., & Jiao, Y. (2024) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2024.117728 · Cited by 13
Kumar, N. N., Ferguson, J. S., Padley, J. R., Pilowsky, P. M., & Goodchild, A. K. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283282e5c · Cited by 13
Hamann, M., Plank, J., Richter, F., Bode, C., Smiljanic, S., Creed, M. C., Nóbrega, J. N., & Richter, A. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.05.051 · Cited by 13
Regulation of the Muscarinic M3 Receptor by Myocardin-Related Transcription Factors
Liu, L., Rippe, C., Hansson, O., Kryvokhyzha, D., Fisher, S. A., Ekman, M., & Swärd, K. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.710968 · Cited by 13
Naznin, F., Waise, T. M. Z., & Fernyhough, P. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03003-1 · Cited by 15
Harada, S., Yamazaki, Y., Koda, S., & Tokuyama, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095433 · Cited by 14
RetractedBerizzi, A. E., Bender, A. M., Lindsley, C. W., Conn, P. J., Sexton, P. M., Langmead, C. J., & Christopoulos, A. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00136 · Cited by 13
Ito, Y., Oyunzul, L., Yoshida, A., Fujino, T., Noguchi, Y., Yuyama, H., Ohtake, A., Suzuki, M., Sasamata, M., Matsui, M., et al. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.04.068 · Cited by 13
Guerriero, C., Manfredelli, M., Matera, C., Iuzzolino, A., Conti, L., Dallanoce, C., Amici, M. D., Trisciuoglio, D., & Tata, A. M. (2023) · Cancers · doi:10.3390/cancers16010025 · Cited by 13
Long-acting muscarinic antagonists for the treatment of chronic obstructive pulmonary disease
Lainé, D. I. (2009) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.09.48 · Cited by 12
DNA-modularized construction of bivalent ligands precisely regulates receptor binding and activation
Zhao, N., Wu, W., Wang, Y., Song, K., Chen, G., Chen, Y., Wang, R., Xu, J., Cui, K., Chen, H., et al. (2023) · Chem · doi:10.1016/j.chempr.2022.12.002 · Cited by 12
Functional characterization of muscarinic autoreceptors in rat and human neocortex
Stoll, C., Eltze, M., Lambrecht, G., Zentner, J., Feuerstein, T. J., & Jackisch, R. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06193.x · Cited by 13
Employing novel animal models in the design of clinically efficacious GPCR ligands
Bradley, S. J., Riaz, S. A., & Tobin, A. B. (2014) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2013.12.002 · Cited by 12
Manicam, C., Perumal, N., Pfeiffer, N., Grus, F. H., & Gericke, A. (2016) · Scientific Reports · doi:10.1038/srep38298 · Cited by 14
The Molecular Mechanisms Underlying Synaptic Transmission
Ashery, U., Bielopolski, N., Lavi, A., Barak, B., Michaeli, L., Ben‐Simon, Y., Sheinin, A., Bar-On, D., Shapira, Z., & Gottfried, I. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418675-0.00002-x · Cited by 16
Mogg, A. J., Eessalu, T. E., Johnson, M., Wright, R. A., Sanger, H., Xiao, H., Crabtree, M. G., Smith, A., Colvin, E. M., Schober, D. A., et al. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.246454 · Cited by 14
Spock, M., Carter, T. R., Bollinger, K. A., Han, C., Baker, L. A., Rodriguez, A. L., Li, P., Dickerson, J. W., Qi, A., Rook, J. M., et al. (2021) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.1c00363 · Cited by 12
Anisuzzaman, A. S. M., Nishimune, A., Yoshiki, H., Uwada, J., & Muramatsu, I. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.182857 · Cited by 12
Sabbir, M. G., Swanson, M., & Albensi, B. C. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1158604 · Cited by 13
Abdelfatah, S., Knorz, C., Ayoobi, A., Omer, E. A., Rosellini, M., Riedl, M., Meesters, C., & Efferth, T. (2024) · Pharmaceuticals · doi:10.3390/ph17010080 · Cited by 14
Carbachol dimers as homobivalent modulators of muscarinic receptors
Matucci, R., Nesi, M., Martino, M. V., Bellucci, C., Manetti, D., Ciuti, E., Mazzolari, A., Dei, S., Guandalini, L., Teodori, E., et al. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.03.012 · Cited by 12
3D-QSAR studies of 2,2-diphenylpropionates to aid discovery of novel potent muscarinic antagonists
Bhattacharjee, A. K., Gordon, J. A., Marek, E., Campbell, A. J., & Gordon, R. K. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.04.001 · Cited by 11
Expression of muscarinic acetylcholine receptors in hepatocytes from rat fibrotic liver
Luo, L., Xu, T., Wang, P., Mao, L., Xi, C., Huang, J., & Zhang, W. (2016) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2016.11.005 · Cited by 11
Photopharmacology in Alzheimer's Disease
Rodríguez‐Soacha, D. A., & Decker, M. W. (2018) · Advanced Therapeutics · doi:10.1002/adtp.201800037 · Cited by 11
Kubota, R., Nomura, W., Iwasaka, T., Ojima, K., Kiyonaka, S., & Hamachi, I. (2018) · ACS Central Science · doi:10.1021/acscentsci.8b00390 · Cited by 10
Jörg, M., van der Westhuizen, E. T., Khajehali, E., Burger, W. A. C., White, J. M., Choy, K. H. C., Tobin, A. B., Sexton, P. M., Valant, C., Capuano, B., et al. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00613 · Cited by 13
Novel M2‐selective, Gi‐biased agonists of muscarinic acetylcholine receptors
Randáková, A., Nelic, D., Ungerová, D., Nwokoye, P. N., Su, Q., Doležal, V., El‐Fakahany, E. E., Boulos, J., & Jakubík, J. (2020) · British Journal of Pharmacology · doi:10.1111/bph.14970 · Cited by 11
Huang, M., Suk, D., Cho, N., Bhattarai, D., Kang, S. B., Kim, Y., Pae, A. N., Rhim, H., & Keum, G. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.02.012 · Cited by 12
Antibodies Against Muscarinic Receptors in Breast Cancer: Agonizing Tumor Growth
Fiszman, G. L., & Sales, M. E. (2008) · Current Immunology Reviews · doi:10.2174/157339508785160732 · Cited by 11
Viberg, A., Martino, G., Lessard, E., & Laird, J. M. A. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9380-3 · Cited by 11
Minarini, A., Marucci, G., Bellucci, C., Giorgi, G., Tumiatti, V., Bolognesi, M. L., Matera, R., Rosini, M., & Melchiorre, C. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.06.025 · Cited by 11
Diphenidol-related diamines as novel muscarinic M4 receptor antagonists
Varoli, L., Andreani, A., Burnelli, S., Granaiola, M., Leoni, A., Locatelli, A., Morigi, R., Rambaldi, M., Bedini, A., Fazio, N., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.03.061 · Cited by 11
Luo, L., Xi, C., Xu, T., Zhang, G., Qun, E., & Zhang, W. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.03.047 · Cited by 10
Muscarinic acetylcholine receptor expression in brain and immune cells of Oreochromis niloticus
Covantes‐Rosales, C. E., Toledo‐Ibarra, G. A., Díaz‐Reséndiz, K. J. G., Ventura‐Ramón, G. H., & Girón‐Pérez, M. I. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.01.012 · Cited by 11
Okimoto, R., Ino, K., Ishizu, K., Takamatsu, H., Sakamoto, K., Yuyama, H., Fuji, H., Someya, A., Ohtake, A., Ishigami, T., et al. (2021) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.121.000709 · Cited by 10
Beneš, J., Nováková, M., Rotková, J., Farár, V., Květňanský, R., RILJAK, V., & Mysliveček, J. (2012) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-011-9781-3 · Cited by 10
Shi, Z., Lü, C., Sun, X., Wang, Q., Chen, S., Li, Y., Qu, L., Chen, L., Bu, L.-L., Liao, D., et al. (2015) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-015-0584-9 · Cited by 11
Frauenknecht, K. B. M., Katzav, A., Grimm, C., Chapman, J., & Sommer, C. (2013) · Immunobiology · doi:10.1016/j.imbio.2013.11.006 · Cited by 10
Atp2c2 Is Transcribed From a Unique Transcriptional Start Site in Mouse Pancreatic Acinar Cells
Fenech, M. A., Sullivan, C., Ferreira, L. T., Mehmood, R., MacDonald, W. A., Stathopulos, P. B., & Pin, C. L. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25391 · Cited by 8
Metadata
- Authors
- Wess, J., Eglen, R. M., & Gautam, D.
- Affiliations
- National Institutes of Health (US)
- PerkinElmer (United States) (US)
- Corresponding author
- Wess, Jürgen
- ORCID
- Wess, Jürgen
- Venue
- Nature Reviews Drug Discovery
- Published
- 2007-09
- Volume
- 6
- Issue
- 9
- Pages
- 721-733
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1999774383
- Cited by
- 637
- References
- 134
- Citations by year
- 2026: 19 · 2025: 23 · 2024: 29 · 2023: 33 · 2022: 21 · 2021: 25 · 2020: 23 · 2019: 29 · 2018: 36 · 2017: 32 · 2016: 38 · 2015: 26 · 2014: 45 · 2013: 40 · 2012: 43
- FWCI
- 3.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- muscarinic receptors, knockout mice, Alzheimer's disease, schizophrenia, pain, obesity, diabetes mellitus, receptor function
- MeSH terms
- Animals, Disease Models, Animal, Ligands, Receptors, Muscarinic, Drug Design, Mice, Knockout, Muscarinic Agonists, Muscarinic Antagonists, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.